Publications by authors named "Ola Landgren"

100Publications

Designing Evolutionary Based Interception Strategies to Block the Transition from Precursor Phases to Multiple Myeloma.

Clin Cancer Res 2020 Aug 5. Epub 2020 Aug 5.

Perlmutter Cancer Center, NYU Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-20-1395DOI Listing
August 2020

Prognostic Factors for Postrelapse Survival after ex Vivo CD34-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma.

Biol Blood Marrow Transplant 2020 Jul 23. Epub 2020 Jul 23.

Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York; The Rockefeller University, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.07.016DOI Listing
July 2020

Management of multiple myeloma during COVID-19 pandemic.

Leuk Res Rep 2020 13;14:100212. Epub 2020 Jun 13.

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lrr.2020.100212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293439PMC
June 2020

The role of high-dose melphalan with autologous stem-cell transplant in multiple myeloma: is it time for a paradigm shift?

Br J Haematol 2020 Jun 5. Epub 2020 Jun 5.

Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16764DOI Listing
June 2020

Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma.

Biol Blood Marrow Transplant 2020 Aug 19;26(8):1394-1401. Epub 2020 May 19.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York; The Rockefeller University, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.04.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371503PMC
August 2020

Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma.

Leukemia 2020 Apr 21. Epub 2020 Apr 21.

Malignant Haematology & Stem Cell Transplantation Service, The Alfred Hospital, Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0834-9DOI Listing
April 2020

Mass Spectrometry-Based Method Targeting Ig Variable Regions for Assessment of Minimal Residual Disease in Multiple Myeloma.

J Mol Diagn 2020 Jul 14;22(7):901-911. Epub 2020 Apr 14.

Hematopathology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2020.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338887PMC
July 2020

Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significance.

J Toxicol Environ Health A 2020 Apr 14;83(7):269-278. Epub 2020 Apr 14.

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15287394.2020.1749919DOI Listing
April 2020

CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging.

Radiology 2020 06 7;295(3):606-615. Epub 2020 Apr 7.

From the Department of Radiology (G.A.U., N.B.S., C.C.R., R.M., L.M.C., S.K.L., J.S.L.), Department of Medical Physics (J.A.O., A.S.K.), Myeloma Service, Department of Medicine (E.S., C.O.L.), and Molecular Pharmacology Program (J.S.L.), Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065; and Department of Radiology, Weill Cornell Medical College, New York, NY (G.A.U., C.C.R., J.S.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2020192621DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263286PMC
June 2020

Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders.

Best Pract Res Clin Haematol 2020 03 17;33(1):101148. Epub 2020 Jan 17.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA; Weill Cornell Medical College, New York, NY, 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2020.101148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410322PMC
March 2020

Second malignancies in multiple myeloma; emerging patterns and future directions.

Best Pract Res Clin Haematol 2020 03 11;33(1):101144. Epub 2020 Jan 11.

Multiple Myeloma Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2020.101144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544243PMC
March 2020

Multiple myeloma: Current advances and future directions.

Authors:
C Ola Landgren

Best Pract Res Clin Haematol 2020 03 5;33(1):101155. Epub 2020 Feb 5.

Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2020.101155DOI Listing
March 2020

Maintenance therapy and need for cessation studies in multiple myeloma: Focus on the future.

Best Pract Res Clin Haematol 2020 03 11;33(1):101140. Epub 2020 Jan 11.

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2020.101140DOI Listing
March 2020

Hemoglobin concentration and risk of arterial and venous thrombosis in 1.5 million Swedish and Danish blood donors.

Thromb Res 2020 02 20;186:86-92. Epub 2019 Dec 20.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Department of Cardiology, Södersjukhuset, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2019.12.011DOI Listing
February 2020

Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma.

Leukemia 2020 05 13;34(5):1476-1480. Epub 2019 Dec 13.

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0689-0DOI Listing
May 2020

Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma: A Review.

JAMA Oncol 2020 Mar;6(3):425-432

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.4659DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430066PMC
March 2020

Fractures and survival in multiple myeloma: results from a population-based study.

Haematologica 2020 04 2;105(4):1067-1073. Epub 2019 Dec 2.

Department of Internal Medicine, Landspitali - The National University Hospital of Iceland, Reykjavik, Iceland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.230011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109735PMC
April 2020

Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime time.

Clin Adv Hematol Oncol 2019 Oct;17(10):559-568

Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451402PMC
October 2019

Distinguishing Drug from Disease by Use of the Hydrashift 2/4 Daratumumab Assay.

J Appl Lab Med 2019 03 31;3(5):857-863. Epub 2018 May 31.

Clinical Chemistry Service, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/jalm.2018.026476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484995PMC
March 2019

Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide.

Sci Rep 2019 10 16;9(1):14884. Epub 2019 Oct 16.

Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-51446-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6795854PMC
October 2019

Presalvage International Staging System Stage and Other Important Outcome Associations in CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Biol Blood Marrow Transplant 2020 01 5;26(1):58-65. Epub 2019 Sep 5.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.08.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470026PMC
January 2020

Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL Amyloidosis.

Biol Blood Marrow Transplant 2020 01 22;26(1):204-208. Epub 2019 Aug 22.

Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.08.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953746PMC
January 2020

Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologics.

Future Oncol 2019 Oct 9;15(28):3267-3281. Epub 2019 Aug 9.

Pfizer, New York, NY 10017, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0368DOI Listing
October 2019

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.

Leukemia 2019 09 24;33(9):2127-2143. Epub 2019 Jul 24.

John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0517-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756042PMC
September 2019

Immune Signatures Associated With Clonal Isotype Switch After Autologous Stem Cell Transplantation for Multiple Myeloma.

Clin Lymphoma Myeloma Leuk 2019 05 3;19(5):e213-e220. Epub 2019 Jan 3.

Adult Hematologic Malignancies and Stem Cell Transplant Program, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH; Case Western Reserve University School of Medicine, Cleveland, OH. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.12.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444684PMC
May 2019

Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS).

Radiology 2019 04 26;291(1):5-13. Epub 2019 Feb 26.

From the Department of Radiology, Royal Marsden Hospital and Institute of Cancer Research, Downs Rd, Sutton SM2 5PT, England (C.M., M.D.B., M.F.K.); Roswell Park Comprehensive Cancer Center, Buffalo, NY (J.H.); Department of Radiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany (S.D., H.P.S.); Department of Radiology, Cancer Center and Institute of Experimental and Clinical Research, Brussels, Belgium (F.E.L.); Department of Radiology, National and Kapodistrian University of Athens, Athens, Greece (L.I.A.); The Royal Marsden Hospital, London, England (D.J.C.); Odense University Hospital, Odense, Denmark (N.A., J.T.A.); Vejle Hospital, Vejle, Denmark (B.Ø.); Memorial Sloan-Kettering Cancer Center, New York, NY (O.L.); and Paul Strickland Scanner Centre, Mount Vernon Hospital, Northwood, England (A.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2019181949DOI Listing
April 2019

Significant Nationwide Variability in the Costs and Hospital Mortality Rates of Autologous Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Nationwide Inpatient Sample Database.

Biol Blood Marrow Transplant 2019 01 6;25(1):41-46. Epub 2018 Sep 6.

Department of Medicine, Weill Cornell Medical College, New York, New York; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183053
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.08.030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661526PMC
January 2019

Biological determinants of health disparities in multiple myeloma.

Blood Cancer J 2018 08 28;8(9):85. Epub 2018 Aug 28.

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41408-018-0118-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127236PMC
August 2018

Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms.

Ann Intern Med 2018 08;169(4):268

Karolinska Institutet, Stockholm, Sweden (T.M.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/L18-0245DOI Listing
August 2018

MRD Testing in Multiple Myeloma: The Main Future Driver for Modern Tailored Treatment.

Semin Hematol 2018 01 5;55(1):44-50. Epub 2018 Mar 5.

Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2018.03.001DOI Listing
January 2018

MRD Testing in Multiple Myeloma: From a Surrogate Marker of Clinical Outcomes to an Every-Day Clinical Tool.

Authors:
Ola Landgren

Semin Hematol 2018 01 15;55(1):1-3. Epub 2018 Mar 15.

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00371963183003
Publisher Site
http://dx.doi.org/10.1053/j.seminhematol.2018.03.003DOI Listing
January 2018

Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival.

Eur J Haematol 2018 Apr 20. Epub 2018 Apr 20.

Myeloma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195866PMC
April 2018

Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance.

Biol Blood Marrow Transplant 2018 04 27;24(4):871-876. Epub 2017 Dec 27.

Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.12.795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6673673PMC
April 2018

Shall we treat smoldering multiple myeloma in the near future?

Authors:
Ola Landgren

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):194-204

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142564PMC
December 2017

Serum protein markers of clonal heterogeneity in myeloma.

Authors:
Ola Landgren

Lancet Haematol 2017 12;4(12):e565-e566

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S23523026173021
Publisher Site
http://dx.doi.org/10.1016/S2352-3026(17)30216-8DOI Listing
December 2017

CAR T cell therapy for multiple myeloma: where are we now and where are we headed?

Leuk Lymphoma 2018 09 6;59(9):2056-2067. Epub 2017 Nov 6.

d Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1393668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936668PMC
September 2018

Racial/ethnic disparities: need more work!

Authors:
Ola Landgren

Blood 2017 10;130(15):1685-1686

MEMORIAL SLOAN KETTERING CANCER CENTER.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-08-798546DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639487PMC
October 2017

A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma.

Clin Pharmacol Ther 2018 Jan 20;103(1):67-76. Epub 2017 Nov 20.

U.S. Food and Drug Administration, Center for Drug Evaluation and Research, National Cancer Institute, Silver Spring, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.871DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418461PMC
January 2018

Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms.

Cancer Chemother Pharmacol 2017 Jul 9;80(1):217-221. Epub 2017 May 9.

Clinical Pharmacology Program, Office of the Clinical Director, National Cancer Institute, 9000 Rockville Pike, Building 10, Rm 5A01, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3323-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387687PMC
July 2017

Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance.

Leuk Lymphoma 2017 12 9;58(12):2962-2965. Epub 2017 May 9.

a Myeloma Service, Division of Hematologic Oncology, Department of Medicine , Memorial Sloan-Kettering Cancer Center , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1312382DOI Listing
December 2017

New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple Myeloma.

Clin Cancer Res 2016 Nov;22(22):5428-5433

Division of Hematology, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587183PMC
November 2016

Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation.

Leuk Lymphoma 2017 08 12;58(8):1823-1831. Epub 2017 Jan 12.

b Department of Medicine, Adult Bone Marrow Transplant Service , Memorial Sloan Kettering Cancer Center, NY Presbyterian Hospital - Weill Cornell Medical College , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1260126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554510PMC
August 2017

Combination therapy for fit (younger and older) newly diagnosed multiple myeloma patients: Data support carfilzomib, lenalidomide, and dexamethasone independent of cytogenetic risk status.

Authors:
Ola Landgren

Semin Oncol 2016 Dec 10;43(6):703-706. Epub 2016 Nov 10.

Myeloma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00937754163011
Publisher Site
http://dx.doi.org/10.1053/j.seminoncol.2016.11.008DOI Listing
December 2016

Monoclonal gammopathy of undetermined significance and Waldenström's macroglobulinemia.

Best Pract Res Clin Haematol 2016 06 4;29(2):187-193. Epub 2016 Sep 4.

Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2016.08.015DOI Listing
June 2016

Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III.

BMC Gastroenterol 2016 Nov 3;16(1):136. Epub 2016 Nov 3.

Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12876-016-0547-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093944PMC
November 2016